Back

The value of biomarkers to assess stroke and bleeding risks in atrial fibrillation patients.

28 August 2021 (11:10 - 11:20)
Organised by:
Congress Presentation Part of: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients Arrhythmias, General Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)

2 More presentations in this session

Presentation thumbnail
NT-proBNP: a valuable marker to screen for Atrial Fibrillation.
Doctor K. Kemp Gudmundsdottir (Reykjavik, IS)
Presentation thumbnail
Q&A.

Access the full session

Session thumbnail
Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 11:10 CET
You may be interested in
thumbnail
Congress Presentation
Serial measurement of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48
29 August 2020
thumbnail
Congress Presentation
Association of antithrombotic therapy with cerebral microbleeds: a cross-sectional, multicentre analysis
28 August 2026
thumbnail
Congress Presentation
Anemia and renal dysfunction predict early major bleeding over stroke in atrial fibrillation with acute heart failure
12 April 2026
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources